Cape Verde vs Djibouti: Previously treated cases tested for RR-/MDR-TB
Cape Verde
20.0%
in 2024
Djibouti
17.0%
in 2022
Cape Verde rank
165th
Djibouti rank
166th
Previously treated cases tested for RR-/MDR-TB over time
- Cape Verde
- Djibouti
How they compare
Cape Verde currently reports 20.0% against 17.0% in Djibouti, a difference of 3.0%.
That makes Cape Verde's figure about 1.2 times Djibouti's.
The two have swapped places 1 time across 6 shared years of data; in 2015 it was Djibouti ahead.
Cape Verde ranks 165th and Djibouti ranks 166th of 180 countries.
Across the 2 decades both report, Cape Verde averaged higher in 1 and Djibouti in 1.
Head to head by decade
| Decade | Cape Verde | Djibouti | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 30.2% | 85.4% | 55.2% | Djibouti |
| 2020s | 100.0% | 17.0% | 83.0% | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Cape Verde or Djibouti?
- Cape Verde, at 20.0% against 17.0% in Djibouti as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Cape Verde and Djibouti?
- 3.0%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Djibouti?
- 6 years are reported by both, from 2015 to 2022.
- How do Cape Verde and Djibouti rank globally for previously treated cases tested for rr-/mdr-tb?
- Cape Verde ranks 165th and Djibouti ranks 166th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.